Indication
Testicular Germ Cell Tumors
1 clinical trial
1 product
1 drug
Clinical trial
A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)Status: Not yet recruiting, Estimated PCD: 2027-10-01
Product
Pembrolizumab